Results 101 to 110 of about 2,337 (220)

J1046+4047: an extremely low-metallicity dwarf star-forming galaxy with O32 = 57 [PDF]

, 2023
Y. I. Izotov, T. X. Thuan, N. G. Guseva
openalex   +1 more source

RP_Combined.RP_WTR_1_5.G38B_P1_1_T-E10.nsp-o32.PMF.digested.fq.gz

, 2018
J. Li
openalex   +1 more source

The crystal structure of a spherical vanadium complex encapsulating a nitrate anion. [PDF]

Acta Crystallogr E Crystallogr Commun
Jordaan R, van Staden C, Kama DV, Purcell W.   +3 more
europepmc   +1 more source

OPPg o32 - Efeito in vitro da adição do hexametafosfato de sódio no cimento de ionômero de vidro na desmineralização do esmalte [PDF]

, 2017
LA Morais, TY Hosida, Acb Delbem, M Danelon, Jas Souza, Denise Pedrini   +5 more
openalex  

A barium complex of a phenoxazinone sulfonate dye. [PDF]

Acta Crystallogr E Crystallogr Commun
Doney JT, Squattrito PJ, Gianopoulos CG.
europepmc   +1 more source

O32 Correlation between different measures of production efficiency in grazing Holstein dairy cows

Animal - science proceedings, 2022
D. Talmón, M. Garcia-Roche, A. Mendoza, M. Carriquiry   +3 more
openaire   +1 more source

Cut-SOAP: A Machine Learning Descriptor for Rapid Screening of Molecular Adsorption Energetics. [PDF]

ACS Omega
Calderan FV, Andriani KF, Felício-Sousa P, Pinheiro GA, Da Silva JLF, Quiles MG.   +5 more
europepmc   +1 more source

Comprehensive Computational Study of a Novel Chromene-Trione Derivative Bioagent: Integrated Molecular Docking, Dynamics, Topology, and Quantum Chemical Analysis. [PDF]

Int J Mol Sci
Sivaprakash P, Viji A, Krishnaveni S, Kavya KM, Lee D, Kim I.   +5 more
europepmc   +1 more source

Elongation Factor Tu Acts as a Chaperone to Activate an Antibacterial RNase Toxin. [PDF]

Mol Microbiol
Nhan DQ, Michalska K, Garza-Sánchez F, Bartelli NL, Willett JLE, Stols L, Eschenfeldt WH, Goulding CW, Joachimiak A, Hayes CS.   +9 more
europepmc   +1 more source

O32 Impact of patient baseline characteristics on SLE Responder Index-4 (SRI[4]) responses to deucravacitinib, a first-in-class, oral, selective, allosteric tyrosine kinase 2 inhibitor in the phase 2 PAISLEY trial in systemic lupus erythematosus [PDF]

Eric F. Morand, Cristina Arriens, Laura Geraldino‐Pardilla, Ann E. Clarke, Samantha Pomponi, Coburn Hobar, Thomas Wegman, R. Koti, Subhashis Banerjee, R. Koti, Ronald van Vollenhoven   +10 more
openalex   +1 more source